MxA is a GTPase that accumulates to high levels in the cytoplasm of in
terferon-treated human cells. Expression of MxA cDNA confers to transf
ected cell lines a high degree of resistance against several RNA virus
es, including influenza, measles, vesicular stomatitis, and Thogoto vi
ruses. We have now generated transgenic mice that express MxA cDNA in
the brain and other organs under the control of a constitutive promote
r. Embryonic fibroblasts derived from the transgenic mice were nonperm
issive for Thogoto virus and showed reduced susceptibility for influen
za A and vesicular stomatitis viruses, The transgenic animals survived
challenges with high doses of Thogoto virus by the intracerebral or i
ntraperitoneal route. Furthermore, the transgenic mice were more resis
tant than their nontransgenic littermates to intracerebral infections
with influenza A and vesicular stomatitis viruses. These results demon
strate that MxA is a powerful antiviral agent in vivo, indicating that
it may protect humans from the deleterious effects of infections with
certain viral pathogens.